相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics
Nicole Moschny et al.
PHARMACEUTICALS (2021)
Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study
Yvonne van der Zalm et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis A Case Report
Marlon Danilewitz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Specific Anti-hostility Effects of Atypical Antipsychotics in Persons with Schizophrenia: From Clozapine to Cariprazine
Leslie Citrome et al.
HARVARD REVIEW OF PSYCHIATRY (2021)
The Impact of Smoking, Sex, Infection, and Comedication Administration on Oral Olanzapine: A Population Pharmacokinetic Model in Chinese Psychiatric Patients
Yan-Nan Zang et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2021)
European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed
Georgios Schoretsanitis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis
Maxim Kuzin et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies
Meysam Zarezadeh et al.
EUROPEAN JOURNAL OF NUTRITION (2021)
Rapid Titration and Decreased Clozapine ClearanceMay Help Explain Five Cases of Clozapine-Induced Myocarditis in a New York Hospital
Jose de Leon et al.
PSYCHOSOMATICS (2020)
Future Studies on the Interaction Between Clozapine and Valproic Acid Should Aspire to Include Longitudinal Designs and Free Valproate Concentrations, and Should Consider that Inducer and/or Inhibitory Effects May Vary With Time, the Individual, and the Auto-Induction of Valproic Acid
Jose de Leon
THERAPEUTIC DRUG MONITORING (2020)
Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study
C. Rohde et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy
Dan Siskind et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Around 3% of 1,300 Levels Were Elevated during Infections in a Retrospective Review of 131 Beijing Hospital In-Patients with More than 24,000 Days of Clozapine Treatment
Can-Jun Ruan et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)
Dose and safety concerns of clozapine: Worldwide package inserts need revisions
Jose de Leon et al.
SCHIZOPHRENIA RESEARCH (2020)
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics
Jose de Leon et al.
WORLD PSYCHIATRY (2020)
20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
Heidi Taipale et al.
WORLD PSYCHIATRY (2020)
Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia
A. G. Villasante-Tezanos et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology
Jose de Leon et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)
Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?
Can-Jun Ruan et al.
PHARMACOGENOMICS (2020)
Sudden Cardiac Death in Schizophrenia: A Review
Jitendra Vohra
HEART LUNG AND CIRCULATION (2020)
Impact of smoking behavior on clozapine blood levels - a systematic review and meta-analysis
E. Wagner et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study
Satish Suhas et al.
SCHIZOPHRENIA RESEARCH (2020)
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents
Edoardo Spina et al.
PHARMACEUTICALS (2020)
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsychiatrie
Georgios Schoretsanitis et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
Do Asian Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Overview
Jose de Leon et al.
INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE (2020)
Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years
Jentien M. Vermeulen et al.
SCHIZOPHRENIA BULLETIN (2019)
A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia
Nicholas Myles et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2019)
A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients
Georgios Schoretsanitis et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies
D. Papola et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics A Systematic Review and Meta-analysis of Cohort Studies
Takahiro Masuda et al.
JAMA PSYCHIATRY (2019)
Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review
Helene Verdoux et al.
SCHIZOPHRENIA RESEARCH (2019)
Exploring the Prevalence of Clozapine Phenotypic Poor Metabolizers in 4 Asian Samples They Ranged Between 2% and 13%
Can-Jun Ruan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
Clozapine Metabolism in East Asians and Caucasians A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review
Can-Jun Ruan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
C. Hiemke et al.
PHARMACOPSYCHIATRY (2018)
Steady-State Clozapine and Norclozapine Pharmacokinetics in Maori and European Patients
David B. Menkes et al.
EBIOMEDICINE (2018)
The Effect of Body Weight Changes on Total Plasma Clozapine Concentrations Determined by Applying a Statistical Model to the Data From a Double-Blind Trial
Francisco J. Diaz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Elevated clozapine levels associated with infection: A systematic review
Scott R. Clark et al.
SCHIZOPHRENIA RESEARCH (2018)
Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study
C. Rohde et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
The significance of sampling time in therapeutic drug monitoring of clozapine
M. I. Jakobsen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Clozapine induced gastrointestinal hypomotility: A potentially life threatening adverse event. A review of the literature
Stephen West et al.
GENERAL HOSPITAL PSYCHIATRY (2017)
Tracing the peopling of the world through genomics
Rasmus Nielsen et al.
NATURE (2017)
Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects
Y. Zhou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
International trends in clozapine use: a study in 17 countries
C. J. Bachmann et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
The impact of clozapine on hospital use: a systematic review and meta-analysis
R. Land et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
Carsten Hjorthoj et al.
LANCET PSYCHIATRY (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Clozapine-induced myocarditis may be associated with rapid titration: A case report verified with autopsy
Nitin Chopra et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2016)
Clozapine V. first-and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
Dan Siskind et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Worldwide Differences in Regulations of Clozapine Use
Jimmi Nielsen et al.
CNS DRUGS (2016)
Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics
Edoardo Spina et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia A Network Meta-analysis
Myrto T. Samara et al.
JAMA PSYCHIATRY (2016)
Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review andMeta-Analysis
Ayala Shirazi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia
Cana Aksoy Poyraz et al.
PSYCHIATRIC QUARTERLY (2016)
Clozapine-induced myocarditis: prescribe safely but do prescribe
O. Freudenreich
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Titrating clozapine amidst recommendations proposing high myocarditis risk and rapid titrations
J. de Leon et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Functional characterization of 20 allelic variants of CYP1A2
Miyabi Ito et al.
DRUG METABOLISM AND PHARMACOKINETICS (2015)
Lamotrigine-induced severe cutaneous adverse reaction: Update data from 1999-2014
Xiang-qing Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Clozapine-induced myocarditis: Separating the wheat from the chaff
Karl Winckel et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2015)
Effectiveness of ultra- rapid dose titration of clozapine for treatment- resistant bipolar mania: case series
Cana Aksoy Poyraz et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
Effectiveness and safety of rapid clozapine titration in schizophrenia
P. Ifteni et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
The prevalence of psychosis in epilepsy; a systematic review and meta-analysis
Maurice J. Clancy et al.
BMC PSYCHIATRY (2014)
Clinically relevant interactions between newer antidepressants and second-generation antipsychotics
Edoardo Spina et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Rapid clozapine titration in treatment-refractory bipolar disorder
Petru Ifteni et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Termination of Clozapine Treatment Due to Medical Reasons: When Is It Warranted and How Can It Be Avoided?
Jimmi Nielsen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers
Maria Dobrinas et al.
PHARMACOGENETICS AND GENOMICS (2013)
Which Metabolites Circulate?
Cho-Ming Loi et al.
DRUG METABOLISM AND DISPOSITION (2013)
Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy
Dan Cohen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: A case-control study
Kathlyn J. Ronaldson et al.
SCHIZOPHRENIA RESEARCH (2012)
A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls
Kathlyn J. Ronaldson et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2011)
Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility
M. Dobrinas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Age-related Changes in Pharmacodynamics: Focus on Drugs Acting on Central Nervous and Cardiovascular Systems
Gianluca Trifiro et al.
CURRENT DRUG METABOLISM (2011)
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
Jari Tiihonen et al.
LANCET (2009)
Effect of Valproate on Olanzapine Plasma Concentrations in Patients With Bipolar or Schizoaffective Disorder
Edoardo Spina et al.
THERAPEUTIC DRUG MONITORING (2009)
The Incidence and Characteristics of Clozapine-Induced Fever in a Local Psychiatric Unit in Hong Kong
Joseph Pui-yin Chung et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2008)
Sex, race, and smoking impact olanzapine exposure
Kristin L. Bigos et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables
F. J. Diaz et al.
PHARMACOPSYCHIATRY (2008)
Serious adverse drug events reported to the food and drug administration, 1998-2005
Thomas J. Moore et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans
Roza Ghotbi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The effect of variable cigarette consumption on the interaction with clozapine and olanzapine
Tore Haslemo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Guidelines for the use of clozapine in individuals with developmental disabilities
Mohamed Sabaawi et al.
RESEARCH IN DEVELOPMENTAL DISABILITIES (2006)
Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients
JOY Wong et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: A predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients
A Rostami-Hodjegan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking
MS Faber et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Identification of a novel splice-site mutation in the CYP1A2 gene
D Allorge et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Olanzapine pharmacokinetics are similar in Chinese and Caucasian subjects
K Sathirakul et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Glucuronidation enzymes, genes and psychiatry
J de Leon
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
What is an adequate trial with clozapine? Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia
PFJ Schulte
CLINICAL PHARMACOKINETICS (2003)
Clozapine treatment for suicidality in schizophrenia - International Suicide Prevention Trial (InterSePT)
HY Meltzer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Contributions of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentrations
OV Olesen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
分享论文
